Journalartikel
Autorenliste: Kranz, Jennifer; Schmidt, Stefanie; Lebert, Cordula; Schneidewind, Laila; Schmiemann, Guido; Wagenlehner, Florian
Jahr der Veröffentlichung: 2017
Seiten: 866-86+
Zeitschrift: Deutsches Ärzteblatt International
Bandnummer: 114
Heftnummer: 50
ISSN: 1866-0452
Open Access Status: Green
DOI Link: https://doi.org/10.3238/arztebl.2017.0866
Verlag: Deutscher Ärzte-Verlag
Background: Uncomplicated bacterial community-acquired urinary tract infection is among the more common infections in outpatient practice. The resistance level of pathogens has risen markedly. This S3 guideline contains recommendations based on current evidence for the rational use of anti microbial agents and for the prevention of inappropriate use of certain classes of antibiotics and thus of the resulting drug resistance. The prevention of recurrent urinary tract infection is considered in this guideline for the first time. Methods: The guideline was updated under the aegis of the German Urological Society (Deutsche Gesellschaft fur Urologie). A systematic literature search (period: 2008-2015) concerning the diagnosis, treatment, and prevention of uncomplicated urinary tract infections was carried out in the Cochrane Library, MEDLINE, and Embase databases. Randomized, controlled trials and systemic reviews were included. Relevant guidelines were identified in a guideline synopsis. Results: Symptom-oriented diagnostic evaluation is highly valued. For the treatment of cystitis, fosfomycin-trometamol, nitrofurantoin, nitroxolin, pivmecillinam and trimethoprim are all equally recommended. Fluorquinolones and cephalosporins are not recommended. Uncomplicated pyelonephritis with a mild to moderate clinical course ought to be treated with oral cefpodoxime, ceftibuten, ciprofloxacin, or levofloxacin. For acute, uncomplicated cystitis, with mild to moderate symptoms, symptomatic treatment alone may be considered instead of antibiotics after discussion of the options with the patient. Mainly non-antibiotic measures are recommended for prophylaxis against recurrent urinary tract infection. Conclusion: Physicians who treat uncomplicated urinary tract infections should familiarize themselves with the newly revised guideline's recommendations on the selection and dosage of antibiotic treatment so that they can responsibly evaluate and plan antibiotic treatment for their affected patients.
Abstract:
Zitierstile
Harvard-Zitierstil: Kranz, J., Schmidt, S., Lebert, C., Schneidewind, L., Schmiemann, G. and Wagenlehner, F. (2017) Uncomplicated Bacterial Community-acquired Urinary Tract Infection in Adults Epidemiology, Diagnosis, Treatment, and Prevention, Deutsches Ärzteblatt International, 114(50), pp. 866-86+. https://doi.org/10.3238/arztebl.2017.0866
APA-Zitierstil: Kranz, J., Schmidt, S., Lebert, C., Schneidewind, L., Schmiemann, G., & Wagenlehner, F. (2017). Uncomplicated Bacterial Community-acquired Urinary Tract Infection in Adults Epidemiology, Diagnosis, Treatment, and Prevention. Deutsches Ärzteblatt International. 114(50), 866-86+. https://doi.org/10.3238/arztebl.2017.0866
Schlagwörter
Acute cystitis; ACUTE PYELONEPHRITIS; ANTIBIOTIC USE; ASYMPTOMATIC BACTERIURIA; CONTROLLED TRIAL; DOUBLE-BLIND; MENTAL-RETARDATION; PLACEBO; WOMEN